CD4 and myeloid sarcoma: Despite the previously mentioned studies suggesting a possible role of LAG3 in the pathogenesis of MS [8,9,10,11,12,13,14,15], the possible contribution of polymorphisms in the LAG3/CD4 genes to the risk for MS has not been still established.